tiprankstipranks
Advertisement
Advertisement
Afya Posts Strong 2025 Results, Boosts Shareholder Payouts and Raises Capital for Next Growth Cycle
PremiumCompany AnnouncementsAfya Posts Strong 2025 Results, Boosts Shareholder Payouts and Raises Capital for Next Growth Cycle
2M ago
Afya downgraded to Neutral from Buy at BofA
Premium
The Fly
Afya downgraded to Neutral from Buy at BofA
2M ago
Afya downgraded to Underweight from Equal Weight at Morgan Stanley
Premium
The Fly
Afya downgraded to Underweight from Equal Weight at Morgan Stanley
3M ago
Afya price target lowered to $18 from $19 at UBS
PremiumThe FlyAfya price target lowered to $18 from $19 at UBS
4M ago
Afya downgraded to Neutral from Overweight at JPMorgan
Premium
The Fly
Afya downgraded to Neutral from Overweight at JPMorgan
4M ago
Afya Limited Announces Upcoming Board of Directors Change
Premium
Company Announcements
Afya Limited Announces Upcoming Board of Directors Change
5M ago
Afya reports Q3 adjusted EBITDA R$398.9M, up 14.6% y/y
PremiumThe FlyAfya reports Q3 adjusted EBITDA R$398.9M, up 14.6% y/y
6M ago
Afya Limited Reports Strong Q3 2025 Financial Results and Strategic Initiatives
Premium
Company Announcements
Afya Limited Reports Strong Q3 2025 Financial Results and Strategic Initiatives
6M ago
Afya Limited Reports Strong Financial Growth in Q3 2025
Premium
Company Announcements
Afya Limited Reports Strong Financial Growth in Q3 2025
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100